Latest AI and machine learning research in dementia for healthcare professionals.
INTRODUCTION: Generative artificial intelligence (GAI), including large language models and multimodal generative systems, is rapidly emerging in healthcare with growing interest in its potential applications for dementia care. These technologies offer new possibilities for communication support, cognitive engagement and personalised interaction, yet they also introduce complex ethical, relational...
BACKGROUND: Accurate prediction of progressive Mild Cognitive Impairment (pMCI) versus stable MCI (sMCI) is crucial for early Alzheimer's disease (AD) intervention and delaying disease progression. The combination of Positron Emission Tomography (PET) and structural Magnetic Resonance Imaging (sMRI) is currently the most recognized diagnostic basis. However, PET and sMRI reveal lesions with hetero...
Sleep disturbances and Alzheimer's disease (AD) are interconnected public health challenges. However, the underlying mechanisms of their complex relat...
BACKGROUND: Traditional cognitive screening relies on episodic clinical assessments and may miss early changes preceding cognitive impairment and deme...
BACKGROUND: Achieving maximal safe resection in glioma surgery requires accurate real-time margin assessment, yet existing technologies have limitatio...
INTRODUCTION: Global ageing populations require accessible, non-invasive tools for early detection and monitoring of neurological chronic and neurodeg...
Volumetric analysis of brain structures is widely used to detect pathological changes in Alzheimer's disease (AD), but it has limited sensitivity to s...
Alzheimer's disease is a slow, progressive neurological disorder that impacts the brain tissue and causes cells to die, the most common reason for dem...
Postoperative delirium (POD) is a common complication in older surgical patients, linked to long-term cognitive decline and progression to dementia, y...
Artificial intelligence (AI) is increasingly integrated into everyday life. Yet in health care, patients and families are challenged to understand how...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder marked by both structural atrophy and functional dysregulation in the brain, yet ...
BACKGROUND: To investigate the radiomics features of the hippocampus and the amygdala subregions in FDG-PET images that can best differentiate Mild Co...
BACKGROUND: Vascular dementia (VaD), known for cognitive issues and cerebrovascular irregularities, is a common dementia type, but its molecular under...
Accurate, early-stage staging of Alzheimer's disease (AD) is critical for therapeutic intervention but is hampered by data privacy regulations, multim...
Alzheimer's disease (AD) is an irreversible neurodegenerative disorder whose progression is closely associated with time. However, most diagnostic mod...
Currently a large number of people living in long-term care facilities suffer from cognitive disorders such as dementia. In this context, new robotic ...
BackgroundNeuroimaging-derived brain age is a promising biomarker of early neurodegeneration, but methodological variation in machine learning (ML) al...
BACKGROUND: Sensor-based footwear is increasingly discussed as a promising tool for mobility monitoring and fall-risk assessment, yet its applicabilit...
Quantitative susceptibility mapping (QSM) on MRI quantifies tissue magnetic susceptibility, which increases with iron accumulation, myelin loss, and n...